Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) — Cash Flow Reinvestment Rate
Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has a Cash Flow Reinvestment Rate of 0.84x as of December 2025, reinvesting TL117.91 Million (capex TL117.91 Million ) from operating cash flow of TL140.82 Million. Explore how much does Meditera Tibbi Malzeme Sanayi ve Ticaret reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Meditera Tibbi Malzeme Sanayi ve Ticaret AS across 8 annual periods. Also explore Meditera Tibbi Malzeme Sanayi ve Ticaret asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)
Year-by-year capital reinvestment analysis for Meditera Tibbi Malzeme Sanayi ve Ticaret AS. For live market cap and broader valuation context, see MEDTR company net worth.
| Year | Reinvestment Rate | Total Reinvested (TRY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | TL191.67 Million | TL435.35 Million | TL191.67 Million | ▼ -18.8% |
| 2024 | 0.54x | TL423.12 Million | TL780.69 Million | TL263.52 Million | ▲ +4.1% |
| 2023 | 0.52x | TL417.10 Million | TL801.02 Million | TL299.70 Million | ▼ -97.2% |
| 2022 | 18.59x | TL94.79 Million | TL5.10 Million | TL51.35 Million | ▲ +4366.2% |
| 2021 | 0.42x | TL15.25 Million | TL36.64 Million | TL8.92 Million | ▲ +46.0% |
| 2020 | 0.29x | TL20.89 Million | TL73.26 Million | TL20.85 Million | ▼ -54.1% |
| 2019 | 0.62x | TL12.42 Million | TL20.01 Million | TL0.00 | ▲ +101.7% |
| 2018 | 0.31x | TL22.55 Million | TL73.26 Million | TL0.00 | — |